Perioperative antibiotic prophylaxis and antimicrobial therapy of intra-abdominal infections

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 30, Issue 5, 2014, Pages 310-316

  Hagel, Stefan ^a   Scheuerlein, Hubert ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Antibiotic resistance; Intra abdominal infections; Perioperative antibiotic prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CEFTAROLINE; CEPHALOSPORIN; DAPTOMYCIN; ECHINOCANDIN; FLUCONAZOLE; LINEZOLID; METRONIDAZOLE; TIGECYCLINE; VANCOMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CANDIDA; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTERIACEAE; GASTROINTESTINAL SURGERY; HUMAN; LOEFFLER PNEUMONIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NAUSEA; PERIOPERATIVE PERIOD; PERITONITIS; POLYNEUROPATHY; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VOMITING; WOUND INFECTION;

EID: 84910636423     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000368582     Document Type: Review

References (26)

1. Behnke M, Hansen S, Leistner R, et al: Nosocomial infection and antibiotic use: A second national prevalence study in Germany. Dtsch Arztebl Int 2013; 110: 627-633.
2. Bratzler DW, Dellinger EP, Olsen KM, et al: Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70: 195-283.
3. Rovera F, Diurni M, Dionigi G, et al: Antibiotic prophylaxis in colorectal surgery. Expert Rev Anti Infect Ther 2005; 3: 787-795.
4. Wacha H, Isenmann R, Kujath P, Lebert C, Naber CK, Salzberger B: Perioperative Antibiotika- Prophylaxe: Empfehlungen einer Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Chemother J 2010; 19: 70-84.
5. Cruse PJ, Foord R: The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60: 27-40.
6. Scottish Intercollegiate Guidelines Network (SIGN): Antibiotic Prophylaxis in Surgery. Edinburgh, SIGN, 2008.
7. Knebel P, Weigand MA, Büchler MW, Seiler CM: Evidence-based antibiotic prophylaxis in general and visceral surgery (article in German). Chirurg 2011; 82: 227-234.
8. Hirokawa F, Hayashi M, Miyamoto Y, et al: Evaluation of postoperative antibiotic prophylaxis after liver resection: A randomized controlled trial. Am J Surg 2013; 206: 8-15.
9. Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L: Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838-1843.
10. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y: Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921.
11. Zylka-Menhorn V: Zu einem guten Chirurgen gehört die saubere Indikationsstellung. Dtsch Ärztebl 2014; 111: 692-693.
12. Bodmann K-F: Komplizierte intraabdominelle Infektionen: Erreger, Resistenzen. Chirurg 2010; 81: 38-49.
13. Engel C, Brunkhorst FM, Bone H-G, et al: Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 2007; 33: 606-618.
14. Solomkin JS, Mazuski JE, Bradley JS, et al: Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 2010; 11: 79-109.
15. Eckmann C, Dryden M, Montravers P, Kozlov R, Sganga G: Antimicrobial treatment of 'complicated' intra-abdominal infections and the new IDSA guidelines? A commentary and an alternative European approach according to clinical definitions. Eur J Med Res 2011; 16: 115-126.
16. Kujath P, Hoffmann M, Rodloff A: Antimicrobial and antimycotic therapy of intra-abdominal infections (article in German). Chirurg 2008; 79: 295-305.
17. Augustin P, Tran-Dinh A, Valin N, et al: Pseudomonas aeruginosa post-operative peritonitis: Clinical features, risk factors, and prognosis. Surg Infect 201314; 14: 297-303.
18. Boucher HW, Talbot GH, Bradley JS, et al: Bad bugs, no drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
19. Meyer E, Schröder C, Gastmeier P, Geffers C: The reduction of nosocomial MRSA infection in Germany - an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Dtsch Arztebl 2014; 111: 331-336.
20. Bassetti M, Eckmann C, Bodmann KF, et al: Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies. J Antimicrob Chemother 2013; 68(suppl 2): Ii5-14.
21. Bodmann K-F, und die Expertenkommission der Infektliga: Complicated intra-abdominal infections: Pathogens, resistance. Recommendations of the Infectliga on antbiotic therapy (article in German). Chirurg 2010; 81: 38-49.
22. Kaase M: Bericht des NRZ für gramnegative Krankenhauserreger. Carbapenemase-tragende gramnegative Erreger im Zeitraum Mai bis Juni 2010. Epidemiol Bull 2010; 28: 267.
23. Ben-David D, Kordevani R, Keller N, et al: Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012; 18: 54-60.
24. Lübbert C, Rodloff AC, Laudi S, et al: Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in liver transplant recipients. Liver Transpl 2014; 20: 736-738.
25. Lübbert C, Becker-Rux D, Rodloff AC, et al: Colonization of liver transplant recipients with KPCproducing Klebsiella pneumoniae is associated with high infection rates and excess mortality: A casecontrol analysis. Infection 2014; 42: 309-316.
26. Cuenca-Estrella M, Verweij PE, Arendrup MC, et al: ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures. Clin Microbiol Infect 2012; 18(suppl 7): 9-18.